Receptor tyrosine kinase inhibitors in cancer.
Ebrahimi N, Fardi E, Ghaderi H, Palizdar S, Khorram R, Vafadar R, Ghanaatian M, Rezaei-Tazangi F, Baziyar P, Ahmadi A, Hamblin MR, Aref AR.
Ebrahimi N, et al.
Cell Mol Life Sci. 2023 Mar 22;80(4):104. doi: 10.1007/s00018-023-04729-4.
Cell Mol Life Sci. 2023.
PMID: 36947256
Review.